| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
group | 0.200 | None | 0.958 | 1 | 0 | 1996 | 2020 | ||||||||
|
solute carrier family 30 member 8 | 0.623 | 0.731 | 7.4E-12 |
|
group | 0.100 | None | 0.961 | 2 | 0 | 2008 | 2019 | ||||||||
|
PPARG coactivator 1 alpha | 0.453 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.962 | 1 | 0 | 2001 | 2019 | ||||||||
|
insulin | 0.445 | 0.923 | 0.30 |
|
group | 0.700 | None | 0.963 | 3 | 0 | 1981 | 2020 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
group | 0.400 | None | 0.967 | 3 | 0 | 2002 | 2020 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
group | 0.100 | None | 0.968 | 1 | 0 | 2004 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
group | 0.200 | None | 0.971 | 2 | 0 | 1991 | 2019 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
group | 0.300 | None | 0.971 | 2 | 0 | 2000 | 2020 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
group | 0.100 | None | 0.972 | 1 | 0 | 1996 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.100 | None | 0.975 | 2 | 0 | 1993 | 2020 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
group | 0.400 | None | 0.976 | 2 | 0 | 2000 | 2020 | ||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
group | 0.200 | None | 0.976 | 1 | 0 | 2006 | 2020 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
group | 0.400 | None | 0.977 | 2 | 0 | 1998 | 2020 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
group | 0.100 | None | 0.977 | 1 | 0 | 2001 | 2020 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 11 | 0.529 | 0.615 | 1.1E-02 |
|
group | 0.200 | None | 0.985 | 9 | 0 | 2003 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.100 | None | 0.990 | 2 | 0 | 1997 | 2020 | ||||||||
|
insulin dependent diabetes mellitus 17 | 0.931 | 0.115 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2004 | 2004 | |||||||||
|
leptin receptor | 0.433 | 0.808 | 0.99 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 1996 | 2019 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 2001 | 2019 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
group | 0.030 | None | 1.000 | 2 | 0 | 1995 | 2004 | ||||||||
|
protein kinase C beta | 0.453 | 0.885 | 1.00 |
|
group | 0.060 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
nicotinamide phosphoribosyltransferase | 0.502 | 0.808 | 0.98 |
|
group | 0.050 | None | 1.000 | 2 | 0 | 2007 | 2018 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.100 | None | 1.000 | 2 | 0 | 1998 | 2019 | ||||||||
|
butyrylcholinesterase | 0.447 | 0.923 | 1.1E-13 |
|
group | 0.100 | None | 1.000 | 1 | 0 | 2002 | 2019 | ||||||||
|
CD36 molecule | 0.446 | 0.846 | 1.1E-60 |
|
group | 0.100 | None | 1.000 | 1 | 0 | 1999 | 2020 |